Related Experiment Video
Updated: Feb 28, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Group A β-hemolytic streptococcus causing purpura fulminans: two case reports
A Alkhatatbeh1, Jiechen Chen1, Yongru Chen2
1Department of Orthopedics Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Abstract:
Purpura fulminans (PF) is a rare, life-threatening emergency characterized by rapidly progressive purpura evolving into hemorrhagic bullae and skin necrosis due to dermal microvascular thrombosis, typically accompanied by shock and disseminated intravascular coagulation (DIC). We report two fatal adult cases of infection-associated PF caused by Streptococcus pyogenes (group A streptococcus). Both patients presented with early gastrointestinal symptoms and rapidly developed septic shock, severe coagulopathy compatible with overt DIC, and extensive lower-limb purpura with bullae and necrosis. Pathogen identification was supported by next-generation sequencing from blood and/or tissue specimens. Management required immediate resuscitation, organ support, targeted anti-group A streptococcal therapy, and surgical source control; nevertheless, both patients deteriorated with refractory multiorgan failure. These cases highlight that gastrointestinal symptoms may precede fulminant invasive S. pyogenes infection with PF and streptococcal toxic shock syndrome overlap. Early recognition of the clinical pattern (shock + rapidly progressive purpura/bullae + DIC) and aggressive multidisciplinary management are essential.
Insights
Purpura fulminans (PF) is a rare, life-threatening emergency. Two fatal cases linked to Streptococcus pyogenes highlight gastrointestinal symptoms preceding invasive infection and the need for rapid, multidisciplinary care.
Area of Science:
- Infectious Diseases
- Hematology
- Dermatology
Background:
- Purpura fulminans (PF) is a rare, life-threatening emergency.
- Characterized by rapidly progressive purpura, hemorrhagic bullae, skin necrosis, dermal microvascular thrombosis, shock, and disseminated intravascular coagulation (DIC).
More Related Videos
09:25Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
Published on: August 19, 2016
11:40Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature
Published on: April 1, 2014
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Endocarditis II: Clinical Features of Infective Endocarditis
Hypersensitivity Reactions: Immune-Complex Reactions
Acute Pyelonephritis II: Diagnostic Studies and Management
Rheumatic Heart Disease III: Medical Management